Saturday 17 October 2026
Export RDY’s income statement to Excel — free account
Dr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025. In the quarter to June 2026, revenue fell 14.4%, EPS fell 70.0%, free cash flow fell 143.4% and total debt rose 34.0%, each against the same quarter a year earlier.
13.05
0.15
+1.16%
Follow RDY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 8.21% | 11.40% | 16.28% | 17.45% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 4 | 4 | 3 | |
| 5.55% | 7.63% | 10.88% | 11.62% | ||
ROIC |
5.89% | 8.55% | 11.88% | 13.05% | |
Return on Tangible Assets |
12.38% | 17.09% | 22.80% | 25.02% | |
Average Days of Receivables |
112.81 | 110.01 | 106.53 | 101.85 | |
Free Cash Flow per Share |
0.18 | 0.26 | 0.35 | 0.26 | |
Free Cash Flow |
139.00 | 215.00 | 288.00 | 220.00 | |
Capital Expenditures |
(287.00) | (392.00) | (429.00) | (453.00) | |
| Other line items | |||||
Cash ROIC |
2.43% | 3.70% | 4.91% | 3.98% | |
Accounts Receivable Turnover |
3.16 | 3.35 | 3.54 | 3.74 | |
Accounts Payable Turnover |
4.12 | 4.38 | 4.03 | 3.91 | |
Inventory Turnover |
1.98 | 2.05 | 2.06 | 2.01 | |
Average Days of Payables |
84.13 | 76.84 | 93.93 | 96.21 | |
Days of Inventory on Hand |
180.59 | 176.13 | 181.86 | 181.38 | |
Tax Rate |
(0.21) | (0.23) | (0.23) | (0.23) | |
Research and Development Expense of Revenue |
7.10% | 7.15% | 7.47% | 7.70% | |
Selling, General and Administrative Expense of Revenue |
33.24% | 31.76% | 29.80% | 29.30% | |
Share Based Compensation of Revenue |
0.09% | 0.08% | 0.10% | 0.13% | |
Interest Coverage |
8.52 | 13.48 | 19.90 | 22.03 | |
Operating CF/Net income |
1.26 | 1.33 | 1.11 | 0.99 | |
Depreciation/Fixed assets |
0.18 | 0.18 | 0.17 | 0.17 | |
Capex/Depreciation |
(1.30) | (1.78) | (1.94) | (2.08) | |
Revenue per Share |
4.39 | 4.30 | 4.73 | 4.74 | |
Operating CF per Share |
0.54 | 0.73 | 0.86 | 0.81 | |
Capex per Share |
(0.37) | (0.47) | (0.52) | (0.54) | |
Capex to Sales |
0.08 | 0.11 | 0.11 | 0.11 |
Columns are period end dates